EP2010155A2
Glucagon-like peptide 1(glp-1) pharmaceutical formulations
Abstract
This record has no abstract on file.
Term
Projected expiry 16 April 2027.
- Priority
- Filed
- Published
- Today
- Projected expiry
Every citation, both ways
| Reference | Relation | Cited during |
|---|---|---|
| See references of WO 2007121411A3 | Non-patent | Search report |
515 members in 25 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 744882P | United States of America | – | |
| 74488206 | United States of America | P | |
| 2007066728 | United States of America | W |
Members515
| Document | Office | Kind | |
|---|---|---|---|
| US947284A | United States of America | A | |
| US953857A | United States of America | A | |
| US1051480A | United States of America | A | |
| US1222558A | United States of America | A | |
| CA2493478A1 | Canada | A1 | |
| WO2004012672A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2003257156A1 | Australia | A1 | |
| US2004038865A1 | United States of America | A1 | |
| WO2004012672A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1545457A2 | European Patent Office (EPO) | A2 | |
| JP2006500961A | Japan | A | |
| US2007059373A1 | United States of America | A1 | |
| US2007059374A1 | United States of America | A1 | |
| AU2006290227A1 | Australia | A1 | |
| AU2006290870A1 | Australia | A1 | |
| CA2620758A1 | Canada | A1 | |
| CA2621806A1 | Canada | A1 | |
| CA2818900A1 | Canada | A1 | |
| WO2007033316A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2007033372A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2007033372A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2007033316A3 | World Intellectual Property Organization (WIPO) | A3 | |
| AU2003257156B2 | Australia | B2 | |
| AU2007238000A1 | Australia | A1 | |
| CA2646400A1 | Canada | A1 | |
| WO2007121411A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2007121411A3 | World Intellectual Property Organization (WIPO) | A3 | |
| KR20080043372A | Republic of Korea | A | |
| KR20080043387A | Republic of Korea | A | |
| EP1928423A2 | European Patent Office (EPO) | A2 | |
| EP1937219A2 | European Patent Office (EPO) | A2 | |
| CN101262849A | China | A | |
| CN101262850A | China | A | |
| US2008260838A1 | United States of America | A1 | |
| MX2008013216A | Mexico | A | |
| HK1116088A | Hong Kong, China | A | |
| HK1116088A1 | Hong Kong, China | A1 | |
| KR20080111533A | Republic of Korea | A | |
| EP2010155A2This record | European Patent Office (EPO) | A2 | |
| HK1117768A | Hong Kong, China | A | |
| HK1117768A1 | Hong Kong, China | A1 | |
| JP2009507929A | Japan | A | |
| JP2009507931A | Japan | A | |
| AU2008316634A1 | Australia | A1 | |
| AU2008316636A1 | Australia | A1 | |
| CA2703234A1 | Canada | A1 | |
| CA2703338A1 | Canada | A1 | |
| US2009110647A1 | United States of America | A1 | |
| US2009111749A1 | United States of America | A1 | |
| WO2009055740A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO2009055742A2 | World Intellectual Property Organization (WIPO) | A2 | |
| CN101453988A | China | A | |
| WO2009055740A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO2009055742A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1545457A4 | European Patent Office (EPO) | A4 | |
| JP2009533476A | Japan | A | |
| US2009232891A1 | United States of America | A1 | |
| RU2008114306A | Russian Federation | A | |
| RU2008114361A | Russian Federation | A | |
| AU2009257311A1 | Australia | A1 | |
| CA2728230A1 | Canada | A1 | |
| CA2982550A1 | Canada | A1 | |
| CA3086027A1 | Canada | A1 | |
| CA3153292A1 | Canada | A1 | |
| US2009308390A1 | United States of America | A1 | |
| US2009308391A1 | United States of America | A1 | |
| US2009308392A1 | United States of America | A1 | |
| WO2009152477A2 | World Intellectual Property Organization (WIPO) | A2 | |
| TW201002378A | Taiwan Province of China | A | |
| WO2009152477A3 | World Intellectual Property Organization (WIPO) | A3 | |
| RU2008144965A | Russian Federation | A | |
| RU2390325C2 | Russian Federation | C2 | |
| MX2010004508A | Mexico | A | |
| MX2010004510A | Mexico | A | |
| CA2749099A1 | Canada | A1 | |
| WO2010080964A1 | World Intellectual Property Organization (WIPO) | A1 | |
| RU2394550C2 | Russian Federation | C2 | |
| AR072114A1 | Argentina | A1 | |
| EP2211842A2 | European Patent Office (EPO) | A2 | |
| US2010197565A1 | United States of America | A1 | |
| EP2214647A2 | European Patent Office (EPO) | A2 | |
| KR20100090692A | Republic of Korea | A | |
| KR20100093055A | Republic of Korea | A | |
| CN101827626A | China | A | |
| BRPI1015976A2 | Brazil | A2 | |
| CA2791847A1 | Canada | A1 | |
| WO2010102148A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US7799344B2 | United States of America | B2 | |
| US7803404B2 | United States of America | B2 | |
| US2010247661A1 | United States of America | A1 | |
| TW201036656A | Taiwan Province of China | A | |
| US2010278924A1 | United States of America | A1 | |
| CN201643274U | China | U | |
| JP2011500850A | Japan | A | |
| JP2011500851A | Japan | A | |
| US2011003004A1 | United States of America | A1 | |
| RU2409349C2 | Russian Federation | C2 | |
| CN101969927A | China | A | |
| CN101969928A | China | A | |
| MX2010013590A | Mexico | A |
Showing 100 of 515
27 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Application deemed to be withdrawnWithdrawn18D | 18D | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWNSTAA | STAA | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | |
| Request for extension of the european patent (deleted)DAX | DAX | |
| First examination report despatched17Q | 17Q | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Information on inventor provided before grant (corrected)RIN1 | RIN1 | |
| Request for examination filed17P | 17P | |
| Designated contracting statesAK | AK | |
| Request for extension of the european patentAX | AX | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI |
Numbers
- Publication
- 2010155
- Application
- 77607281
Titles3
- German
- PHARMAZEUTISCHE GLUCAGON-ÄHNLICHE PEPTID1-FORMULIERUNGEN
- English
- GLUCAGON-LIKE PEPTIDE 1(GLP-1) PHARMACEUTICAL FORMULATIONS
- French
- FORMULATIONS PHARMACEUTIQUES À PEPTIDE APPARENTÉ AU GLUCAGON 1(GLP-1)
Classification
- CPC, 27
- A61K9/0075
- A61K9/16
- A61K9/19
- A61K9/0019
- A61K9/08
- A61K9/143
- A61K9/145
- A61K38/26
- A61K45/06
- A61P1/00
- A61P1/04
- A61P1/18
- A61P3/00
- A61P3/04
- A61P3/06
- A61P3/10
- A61P9/00
- A61P9/10
- A61P25/00
- A61P25/28
- A61P35/00
- A61P37/06
- A61P43/00
- A61K9/0073
- A61K9/1611
- A61K9/1682
- A61K31/496
- IPC, 2
- A61K9 16
- A61K38 26
Designated states37
- Contracting states, 32
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Hungary
- Ireland
- Iceland
- Italy
- Liechtenstein
- Lithuania
- Luxembourg
- Latvia
- Monaco
- Malta
and 8 moreShow fewer
- Netherlands (Kingdom of the)
- Poland
- Portugal
- Romania
- Sweden
- Slovenia
- Slovakia
- Türkiye
- Extension states, 5
- Albania
- Bosnia and Herzegovina
- Croatia
- North Macedonia
- Serbia